NAT10 induces glycolysis and immunosuppressive tumor microenvironment by upregulating the upstream genes of glycolysis such as FOXP1 and JunB by stimulating ac4C modification of their mRNAs [106, 135]. The gene discussed is NAT10; the disease is neoplasm.